Cardiovascular Drugs Market Global Report 2017

Cardiovascular disorders drug market covers the drugs used to treat conditions that affect heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anticoagulants such as Rivaroxaban (Xarelto), Dabigatran (Pradaxa), Apixaban (Eliquis), Heparin, and Warfarin.

The global cardiovascular disorders drugs market was estimated to be around $126 billion as of 2016. The cardiovascular disorders drugs market made up around 12% of the overall pharmaceuticals market in 2016. The cardiovascular disorders drugs market was the third largest market, following the pharmaceutical drugs and biologics market in the global pharmaceutical market in 2016.

Development Of Personalized Medicine For The Treatment Of Cardiovascular Diseases
Innovation of gene testing technologies for the development of personalized medicine for cardiovascular diseases is one of the major trend in the market. Due to the reduction in the cost of gene testing, patients can screen for their predisposition for specific cardiovascular diseases. Gene testing helps in development of personalized pharmacogenomic agents and improved patient monitoring efforts and detect them before an onset of acute care episodes.

1. Cardiovascular Drugs Market Characteristics;

2. Cardiovascular Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Cardiovascular Drugs Market Customer Information;

5. Cardiovascular Drugs Market Segmentation;
5.1. Global Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 5.2. Global Cardiovascular Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Cardiovascular Drugs Market Trends And Strategies;

6. Cardiovascular Drugs Market Regional And Country Analysis;
6.1. Global Cardiovascular Drugs Market, 2016, By Region; 6.2. Global Cardiovascular Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Cardiovascular Drugs Market, 2016, By Country; 6.4. Cardiovascular Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country

7. Global Cardiovascular Drugs Market Comparison With Macro Economic Factors;
7.1. Cardiovascular Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Cardiovascular Drugs Expenditure, Global;

8. Cardiovascular Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Cardiovascular Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Cardiovascular Drugs Expenditure, By Country;

9. Cardiovascular Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Cardiovascular Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Cardiovascular Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Cardiovascular Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Cardiovascular Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Hypertension, 2014, By Country; 9.10. Prevalent Cases Of Parkinsons Disease, 2014, By Country; 9.11. Global Number Of General Practitioners 2016, By Country; 9.12. Global Cardiovascular Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Cardiovascular Drugs Market;
10.1.1. Asia-Pacific Cardiovascular Drugs Market Overview; 10.1.2. Asia-Pacific Cardiovascular Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Cardiovascular Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 10.2. Asia-Pacific Cardiovascular Drugs Market: Country Analysis; 10.3. China Cardiovascular Drugs Market; 10.3.1. China Cardiovascular Drugs Market Overview; 10.3.2. China Cardiovascular Drugs Historic Market, 2012 - 2016; 10.3.3. China Cardiovascular Drugs Forecast Market, 2016 - 2020; 10.3.4. China Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 10.3.5. China Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 10.4. India Cardiovascular Drugs Market; 10.4.1. India Cardiovascular Drugs Market Overview; 10.4.2. India Cardiovascular Drugs Historic Market, 2012 - 2016; 10.4.3. India Cardiovascular Drugs Forecast Market, 2016 - 2020; 10.4.4. India Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 10.4.5. India Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 10.5. Japan Cardiovascular Drugs Market; 10.5.1. Japan Cardiovascular Drugs Market Overview; 10.5.2. Japan Cardiovascular Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Cardiovascular Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 10.5.5. Japan Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 10.6. Australia Cardiovascular Drugs Market; 10.6.1. Australia Cardiovascular Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Cardiovascular Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 10.6.4. Australia Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020;

11. Western Europe Cardiovascular Drugs Market;
11.1.1. Western Europe Cardiovascular Drugs Market Overview; 11.1.2. Western Europe Cardiovascular Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Cardiovascular Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 11.2. Western Europe Cardiovascular Drugs Market: Country Analysis; 11.3. UK Cardiovascular Drugs Market; 11.3.1. UK Cardiovascular Drugs Market Overview; 11.3.2. UK Cardiovascular Drugs Historic Market, 2012 - 2016; 11.3.3. UK Cardiovascular Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 11.3.5. UK Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 11.4. Germany Cardiovascular Drugs Market; 11.4.1. Germany Cardiovascular Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Cardiovascular Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 11.4.4 Germany Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 11.5 France Cardiovascular Drugs Market; 11.5.1 France Cardiovascular Drugs Historic Market, 2012 - 2016; 11.5.2 France Cardiovascular Drugs Forecast Market, 2016 - 2020; 11.5.3 France Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 11.5.4 France Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 11.6. Italy Cardiovascular Drugs Market; 11.6.1. Italy Cardiovascular Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Cardiovascular Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 11.6.4. Italy Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020; 11.7. Spain Cardiovascular Drugs Market; 11.7.1. Spain Cardiovascular Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Cardiovascular Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 11.7.4. Spain Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020;

12. Eastern Europe Cardiovascular Drugs Market;
12.1.1. Eastern Europe Cardiovascular Drugs Market Overview; 12.1.2. Eastern Europe Cardiovascular Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Cardiovascular Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 12.2. Eastern Europe Cardiovascular Drugs Market: Country Analysis; 12.3. Russia Cardiovascular Drugs Market; 12.3.1. Russia Cardiovascular Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Cardiovascular Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 12.3.4. Russia Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020;

13. North America Cardiovascular Drugs Market;
13.1.1. North America Cardiovascular Drugs Market Overview; 13.1.2. North America Cardiovascular Drugs Historic Market, 2012 - 2016; 13.1.3. North America Cardiovascular Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 13.2. North America Cardiovascular Drugs Market: Country Analysis; 13.3. USA Cardiovascular Drugs Market; 13.3.1. USA Cardiovascular Drugs Historic Market, 2012 - 2016; 13.3.2. USA Cardiovascular Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 13.3.4. USA Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020;

14. South America Cardiovascular Drugs Market;
14.1.1. South America Cardiovascular Drugs Market Overview; 14.1.2. South America Cardiovascular Drugs Historic Market, 2012 - 2016; 14.1.3. South America Cardiovascular Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 14.2. South America Cardiovascular Drugs Market: Country Analysis; 14.3. Brazil Cardiovascular Drugs Market; 14.3.1. Brazil Cardiovascular Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Cardiovascular Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs); 14.3.4. Brazil Cardiovascular Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Cardiovascular Drugs Expenditure, 2012 - 2020;

15. Middle East Cardiovascular Drugs Market;
15.1.1. Middle East Cardiovascular Drugs Market Overview; 15.1.2. Middle East Cardiovascular Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Cardiovascular Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs);

16. Africa Cardiovascular Drugs Market;
16.1.1. Africa Cardiovascular Drugs Market Overview; 16.1.1. Africa Cardiovascular Drugs Market Overview; 16.1.2. Africa Cardiovascular Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Cardiovascular Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Cardiovascular Drugs Market, 2016, By Segment; Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrythmic And Anti-Anginal Drugs);

17. Cardiovascular Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Bristol-Myers Squibb Company; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Abbott Laboratories Inc.; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Astrazeneca Plc; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Bayer Ag; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Novartis Ag; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Cardiovascular Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5 Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer